U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06822712) titled 'Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions' on Feb. 06.

Brief Summary: Evaluating the Safety and Efficacy of Sirolimus-coated Coronary Balloon Dilatation Catheter vs Paclitaxel-coated balloon catheter for the Treatment of De Novo Coronary Bifurcation Lesions

Study Start Date: Feb., 2025

Study Type: INTERVENTIONAL

Condition: Coronary Arterial Disease (CAD)

Intervention: DEVICE: Sirolimus-coated Balloon Dilatation Catheter

During PCI, percutaneous transluminal coronary angioplasty is performed on the target lesion using the Sirolimus-coated Balloon Dilat...